C12N 2710/16541
Use of virus, viral particle or viral elements as a vector
C12N2710/16541 (Use of virus, viral particle or viral elements as a vector) appears on 4 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 9
- Assignees
- 5
- Inventors
- 17
- Latest grant
- 4 Feb 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 0 | 1 |
| 2012 | 1 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
By publication year.
Subgroups
Granted patents
- C12N 2710/16543Viral genome or elements thereof as genetic vectorIndexing code4
- C12N 2710/16542Virus or viral particle as vehicleIndexing code0
- C12N 2710/16544Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
- C12N 2710/16545Special targeting system for viral vectorsIndexing code0
Recent patents
- Recombinant virus vector originating in HHV-6 or HHV-7, method of producing the same, method of transforming host cell using the same, host cell transformed thereby and gene therapy method using the same4 Feb 2014US 8,642,045 B2Virus Ikagaku Kenkyusho Inc.
- Recombinant viral vector for gene transfer into lymphoid cells3 Apr 2012US 8,148,060 B2The Research Foudation for Microbial Diseases of Osaka University
- Recombinant viral vector for gene transfer into lymphoid cells26 Oct 2010US 7,820,436 B2The Research Foundation for Microbial Diseases of Osaka University
- Lymphotropic agents and vectors7 Jan 2003US 6,503,752 B1Ramot University Authority for Applied Research and Industrial Development Ltd.
- Use of the u94 molecule of human herpesvirus 6 and derivatives thereof to increase or induce the expression of the hla-g molecule12 Aug 2021US 2021/0246456 A1
- Enhancer for promoter, and use thereof30 Aug 2012US 2012/0220028 A1The Research Foundation for Microbial Diseases of Osaka University
- Recombinant viral vector for gene transfer into lymphoid cells24 May 2012US 2012/0129263 A1The Research Foundation for Microbial Diseases of Osaka University
- Recombinant viral vector for gene transfer into lymphoid cells24 Mar 2011US 2011/0070651 A1The Research Foudation for Microbial Diseases of Osaka University
- Recombinant virus vector originating in HHV-6 or HHV-7, method of producing the same, method of transforming host cell using the same, host cell transformed thereby and gene therapy method using the same30 Sep 2010US 2010/0247486 A1Virus Ikagaku Kenkyusho Inc.
Most cited
By later US patents
- Recombinant virus vector originating in HHV-6 or HHV-7, method of producing the same, method of transforming host cell using the same, host cell transformed thereby and gene therapy method using the same3US 8,642,045 B2Virus Ikagaku Kenkyusho Inc. · 2014
- Recombinant viral vector for gene transfer into lymphoid cells2US 7,820,436 B2The Research Foundation for Microbial Diseases of Osaka University · 2010
- Lymphotropic agents and vectors1US 6,503,752 B1Ramot University Authority for Applied Research and Industrial Development Ltd. · 2003